189 related articles for article (PubMed ID: 22693873)
1. [Distribution of pulmonary Mycobacterium avium complex (MAC) disease cavities and their course under chemotherapy].
Kurashima A; Horibe M
Kekkaku; 2012 May; 87(5):397-402. PubMed ID: 22693873
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease.
Hasegawa N; Nishimura T; Ohtani S; Takeshita K; Fukunaga K; Tasaka S; Urano T; Ishii K; Miyairi M; Ishizaka A
Chest; 2009 Dec; 136(6):1569-1575. PubMed ID: 19542259
[TBL] [Abstract][Full Text] [Related]
3. [The distribution and the characteristics in computed tomography (CT) of the lungs in primary Mycobacterium avium complex (MAC) infection].
Kitahara Y; Harada Y; Harada S; Maruyama M; Kajiki A; Takamoto M; Ishibashi T
Kekkaku; 1997 Apr; 72(4):173-80. PubMed ID: 9145646
[TBL] [Abstract][Full Text] [Related]
4. Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.
Lee G; Lee KS; Moon JW; Koh WJ; Jeong BH; Jeong YJ; Kim HJ; Woo S
Ann Am Thorac Soc; 2013 Aug; 10(4):299-306. PubMed ID: 23952847
[TBL] [Abstract][Full Text] [Related]
5. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
Ogawa K; Sano C
Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
[TBL] [Abstract][Full Text] [Related]
6. [Perspective of pulmonary MAC infection treatment].
Kurashima A
Kekkaku; 2007 Mar; 82(3):195-9. PubMed ID: 17444124
[TBL] [Abstract][Full Text] [Related]
7. Chronic necrotizing pulmonary aspergillosis complicated by a cavitary lesion caused by Pulmonary Mycobacterium-avium complex disease.
Kobashi Y; Yoshida K; Miyashita N; Niki Y; Matsushima T
Intern Med; 2005 Mar; 44(3):246-50. PubMed ID: 15805716
[TBL] [Abstract][Full Text] [Related]
8. Successful resumption of tocilizumab for rheumatoid arthritis after resection of a pulmonary Mycobacterium avium complex lesion: a case report.
Namkoong H; Tasaka S; Akiyama M; Yagi K; Ishii M; Suzuki K; Kohno M; Hasegawa N; Takeuchi T; Betsuyaku T
BMC Pulm Med; 2015 Oct; 15():126. PubMed ID: 26496968
[TBL] [Abstract][Full Text] [Related]
9. Small-Cell Lung Cancer Comorbid with Pulmonary Mycobacterium avium Infection: A Case Report.
Yamasaki M; Funaishi K; Saito N; Sakamoto KI; Ishiyama S; Kawamoto K; Matsumoto Y; Matsumoto N; Taniwaki M; Ohashi N; Hattori N
Chemotherapy; 2018; 63(5):257-261. PubMed ID: 30466088
[TBL] [Abstract][Full Text] [Related]
10. Characteristic chest CT findings for progressive cavities in Mycobacterium avium complex pulmonary disease: a retrospective cohort study.
Oshitani Y; Kitada S; Edahiro R; Tsujino K; Kagawa H; Yoshimura K; Miki K; Miki M; Kida H
Respir Res; 2020 Jan; 21(1):10. PubMed ID: 31915013
[TBL] [Abstract][Full Text] [Related]
11. [Non-tuberculous mycobacteriosis. What has been coming out].
Kajiki A
Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
[TBL] [Abstract][Full Text] [Related]
12. Impact of rifampicin on the pharmacokinetics of clarithromycin and 14-hydroxy clarithromycin in patients with multidrug combination therapy for pulmonary Mycobacterium avium complex infection.
Iketani O; Komeya A; Enoki Y; Taguchi K; Uno S; Uwamino Y; Matsumoto K; Kizu J; Hasegawa N
J Infect Chemother; 2022 Jan; 28(1):61-66. PubMed ID: 34706852
[TBL] [Abstract][Full Text] [Related]
13. Analysis of chest CT in patients with Mycobacterium avium complex pulmonary disease.
Fujiuchi S; Matsumoto H; Yamazaki Y; Nakao S; Takahashi M; Satoh K; Takeda A; Okamoto K; Fujita Y; Fujikane T; Shimizu T
Respiration; 2003; 70(1):76-81. PubMed ID: 12584395
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary Mycobacterium avium-intracellulare complex disease that presented multiple nodular shadows rapidly].
Fujiwara K
Kyobu Geka; 2009 Sep; 62(10):900-3. PubMed ID: 19764498
[TBL] [Abstract][Full Text] [Related]
15. CT features of pulmonary Mycobacterium avium complex infection.
Lynch DA; Simone PM; Fox MA; Bucher BL; Heinig MJ
J Comput Assist Tomogr; 1995; 19(3):353-60. PubMed ID: 7790541
[TBL] [Abstract][Full Text] [Related]
16. The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease.
Fujita M; Kajiki A; Tao Y; Miyazaki M; Ouchi H; Harada E; Ikegame S; Matsumoto T; Uchino J; Watanabe K; Nakanishi Y
J Infect Chemother; 2012 Apr; 18(2):146-51. PubMed ID: 21927844
[TBL] [Abstract][Full Text] [Related]
17. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease.
Lam PK; Griffith DE; Aksamit TR; Ruoss SJ; Garay SM; Daley CL; Catanzaro A
Am J Respir Crit Care Med; 2006 Jun; 173(11):1283-9. PubMed ID: 16514112
[TBL] [Abstract][Full Text] [Related]
18. A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease.
Kobashi Y; Matsushima T; Oka M
Respir Med; 2007 Jan; 101(1):130-8. PubMed ID: 16750618
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
Miwa S; Shirai M; Toyoshima M; Shirai T; Yasuda K; Yokomura K; Yamada T; Masuda M; Inui N; Chida K; Suda T; Hayakawa H
Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.
Ramirez J; Mason C; Ali J; Lopez FA
J La State Med Soc; 2008; 160(5):248-54; quiz 254, 293. PubMed ID: 19048978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
